RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future
- RXi uses a unique version of RNAi technology called sd-rxRNA.
- RXi has a family tree thatincludes Galena, CytRX, and several RNAi companies.
- Controversies with Galena/CytRX may be having a negative impact on RXi.
- RXI-109 shows promise in scarring and keloids, possibilities in other areas.
- Upside potential seems to outweigh downside risk currently.